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Abstract
Despite the numerous studies of protein kinase CK2, little progress has been made in understanding its function in
chondrocyte death. Our previous study first demonstrated that CK2 is involved in apoptosis of rat articular chondrocytes.
Recent studies have suggested that CK2 downregulation is associated with aging. Thus examining the involvement of CK2
downregulation in chondrocyte death is an urgently required task. We undertook this study to examine whether CK2
downregulation modulates chondrocyte death. We first measured CK2 activity in articular chondrocytes of 6-, 21- and 30-
month-old rats. Noticeably, CK2 activity was downregulated in chondrocytes with advancing age. To build an in vitro
experimental system for simulating tumor necrosis factor (TNF)-a-induced cell death in aged chondrocytes with decreased
CK2 activity, chondrocytes were co-treated with CK2 inhibitors and TNF-a. Viability assay demonstrated that CK2 inhibitors
facilitated TNF-a-mediated chondrocyte death. Pulsed-field gel electrophoresis, nuclear staining, flow cytometry, TUNEL
staining, confocal microscopy, western blot and transmission electron microscopy were conducted to assess cell death
modes. The results of multiple assays showed that this cell death was mediated by apoptosis. Importantly, autophagy was
also involved in this process, as supported by the appearance of a punctuate LC3 pattern and autophagic vacuoles. The
inhibition of autophagy by silencing of autophage-related genes 5 and 7 as well as by 3-methyladenine treatment protected
chondrocytes against cell death and caspase activation, indicating that autophagy led to the induction of apoptosis.
Autophagic cells were observed in cartilage obtained from osteoarthritis (OA) model rats and human OA patients. Our
findings indicate that CK2 down regulation facilitates TNF-a-mediated chondrocyte death through apoptosis and
autophagy. It should be clarified in the future if autophagy observed is a consequence versus a cause of the degeneration in
vivo.
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Introduction
Osteoarthritis (OA) is characterized by the destruction of
extracellular matrix and the loss of chondrocyte function [1].
Chondrocyte depletion was found to be a persistent and
important event in OA. Mechanical injury, loss of extracellular
matrix, loss of growth factors or excessive reactive oxygen species
can induce chondrocyte depletion [2]. Because articular chon-
drocytes are solely responsible for the production and mainte-
nance of the extracellular matrix, chondrocyte depletion is
implicated in cartilage degeneration, which pertains to OA
pathogenesis [3,4]. Because apoptosis was believed to be a major
cause of such cell depletion, most previous studies examining
chondrocyte depletion during OA progression had focused on
chondrocyte apoptosis. A variety of stimuli, such as nitric oxide
(NO) [5], prostaglandin E2 [6], Fas ligand [7], tumor necrosis
factor (TNF)-a [8], and TNF-related apoptosis-inducing ligand
(TRAIL) [9] have been reported to induce apoptosis in
chondrocytes. Enhanced chondrocyte apoptosis is now consid-
ered to be a sign of progressive cartilage joint degeneration in
OA. However, an important question regarding the extent of the
contribution of apoptotic cell death to chondrocyte depletion
during OA progression remains unresolved. Several studies
support the idea that another type of cell death, necrosis, can
be involved in chondrocyte death during OA progression [2].
The role of cytokines in OA has been studied extensively.
Among the inflammatory mediators associated with joint diseases,
TNF-a has been established as a key mediator in the progression
of cartilage degeneration. TNF-a promotes the further expression
of cytokines and chemokines in synovial cells and chondrocytes,
thereby maintaining the renewal of local inflammatory mediators
[10,11]. The presence of TNF-a correlates with a general loss of
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due to the increased production of matrix metalloproteinases and
synthesis of matrix molecules [12].
TNF-a induces apoptosis in chondrocytes by two mechanisms:
direct induction of apoptosis and indirect priming of cells for
apoptosis by Fas ligand presentation [8,13]. The Bcl-2/Bax family
of proto-oncogenes is known to involve in the cellular signaling
pathways of chondrocyte apoptosis induced by TNF-a.A
transcription factor NF-kB is also involved in this process [14].
These pathways lead to the activation of effector caspases (such as
caspase-3) that cleave cellular proteins. During apoptosis, caspases
target housekeeping, structural and cytoskeletal proteins and
activate inhibitors of caspase-activated deoxyribonuclease or poly
(ADP-ribose) polymerase (PARP) [15].
Protein kinase (PK) CK2, which is ubiquitously distributed in
the cytoplasm and nuclei of eukaryotic cells, is a messenger-
independent protein serine/threonine kinase [16,17]. Previous
studies have indicated that CK2 participates in a series of complex
cellular functions, including cell growth and proliferation, by
catalyzing the phosphorylation of a large number of proteins [18].
CK2 also participates in the regulation of apoptosis by
phosphorylating some apoptosis-related factors [18–21]. We
previously demonstrated that CK2 is involved in NO-induced
apoptosis of rat articular chondrocytes [22]. Despite the numerous
studies of CK2, however, little progress has been made in
understanding its function in chondrocytes.
Recent studies have suggested that CK2 downregulation is
associated with aging. One study demonstrated that downregula-
tion of CK2 activity is tightly associated with cellular senescence as
well as with organismal aging [23]. In addition, CK2 was shown to
play a critical role in regulating cytoskeletal reorganization during
senescence progression [24]. It was also reported that silencing of
the CK2a and CK2a’ genes during cellular senescence is
mediated by DNA methylation [25]
This study was undertaken to examine whether CK2 down-
regulation is involved in OA pathogenesis. As shown by our
results, CK2 activity is downregulated in chondrocytes of aged
articular cartilage, and the inhibition of CK2 activity by CK2
inhibitor treatment sensitizes TNF-a mediated chondrocyte death
in vitro through apoptosis and autophagy. In addition, we observed
puncta formation of microtubule-associated protein 1 light chain 3
(LC3) in chondrocytes from cartilage obtained from both human
OA patients and rats with surgically induced OA, indicating that
autophagy is involved in OA pathogenesis.
Materials and Methods
Ethics statement
The animal protocol used in CK2 activity assay was reviewed
and approved by the Pusan National University-Institutional
Animal Care and Use Committee (PNU-2008-0008) under their
ethical procedures and scientific care. The animal protocols used
in cell culture and rat OA model were reviewed and approved by
the Dong-A University-Institutional Animal Care and Use
Committee under their ethical procedures and scientific care
(DIACUC-07-8). The study using Human samples was reviewed
and approved by the Dong-A University Hospital Institutional
Review Board (DUHIRB-10-10-23). Written informed consent
was obtained from all participants.
Reagents
The following reagents were obtained commercially: poly-
clonal rabbit anti-human caspase-2L and caspase-8 from Santa
Cruz Biotechnology (Santa Cruz, CA); caspase-3 antibody and
HRP-conjugated goat anti-rabbit IgGs from Cell Signalling
Technology (Beverly, MA); LC3 antibody from Novus Biolog-
icals (Littleton, CO); ATG5 and ATG7 antibodies from
Abonova (Taipei, Taiwan); FITC-conjugated goat anti-rabbit
IgGs from Vector (Burlingame, CA); TNF-a and ApopTag Red
In Situ Apoptosis Detection Kit from Millipore (Temecular,
CA); Dulbecco’s Modified Eagle’s Medium (DMEM) and fetal
bovine calf serum (FBS) from Gibco (Gaithersburg, MD);
Lysotracker from Invitrogen (C a r l s b a d ,C A ) ;D R A Q 5 T Mf r o m
Axxora (San Diego, CA); b-actin antibody, dimethyl sulfoxide
(DMSO), RNase A, proteinase K, protease inhibitor cocktail,
propidium iodide (PI), 3-methyladenine (3MA), bafilomycin A1,
5,6-dichlorobenzimidazol riboside (DRB), apigenin, 4,5,6,7-
tetrabromobenzotriazole (TBB) and type II collagenase from
Sigma (St. Louis, MO); Super Signal West Pico Chemilumines-
cent Substrate from Pierce (Rockford, IL).
CK2 activity assay
Specific pathogen-free male Sprague Dawley rats were
obtained from Samtako (Osan, Korea). Animals were housed
individually in polycarbonate cages with wood chip bedding and
were maintained in an air-conditioned animal room (tempera-
ture: 24uC, relative humidity: 5565%) on a 12-hr light/dark
cycle at Pusan National University for 7 days. The rats (6, 21 and
30 months of age) were killed and the knee joint cartilage was
used for the CK2 activity assay. Three animals were used from
each age group. CK2 activity was measured as previously
described with slight modification [26]. Three micrograms of
bacterially expressed GST-CS (CK2 substrate) protein were
incubated with glutathione sepharose 4B beads (GE Healthcare)
for 30 min, after which they were washed twice with 16 kinase
buffer (4 mM MOPS, pH 7.2, 5 mM b-glycerol phosphate,
1 mM EGTA, 200 mM sodium orthovanadate and 200 mM
dithiothreitol). The beads were then incubated with 100 mgo f
total cell lysate in 50 ml of kinase reaction buffer [10 mlo f5 6
kinase buffer and 10 ml of magnesium/ATP cocktail solution
(90 ml of 75 mM MgCl2/500 mM ATP plus 10 ml( 1 0 0mCi) of
[c-
32P]-ATP (3000 Ci/mmole)] for 30 min at 30uC. For
experimental and negative controls, the beads were incubated
with 50 ng recombinant active CK2 (Millipore) and without cell
lysates, respectively. The reactions were stopped by washing twice
with 16kinase buffer. The samples were resuspended in 30 mlo f
16 SDS loading buffer and subjected to SDS-PAGE and
autoradiography. CK2 activity was quantified by counting the
radioactivity of each excised GST-CS band using a b-counter.
Cell culture of articular chondrocytes
Five-week-old male specific pathogen-free Sprague Dawley rats
were obtained from Samtako (Osan, Korea). Rat articular
chondrocytes for primary culture were isolated from knee joint
cartilage slices by enzymatic digestion for 1 h with 0.2% type II
collagenase (381 units/mg) in DMEM. After the isolated cells were
collected by brief centrifugation, they were resuspended in
DMEM supplemented with 10% (v/v) FBS, 50 mg/ml streptomy-
cin and 50 units/ml penicillin (Gibco). The cells were plated on
culture dishes at a density of 5610
4 cells/cm
2. The medium was
replaced every 2 days, and they reached confluence after
approximately 5 days in culture.
Treatment of TNF-a and pharmacological reagents
To induce cell death, chondrocytes from day 4 cultures were
treated with TNF-a. To examine whether the inhibition of CK2
activity modulates the extent of TNF-a-mediated chondrocyte
death, cells were incubated with one of three CK2 inhibitors
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examine the effect of inhibition of autophagy on chondrocyte
death, cells were pretreated with 3MA for 24 h and were further
exposed to TNF-a in the presence or absence of the CK2 inhibitor
DRB for 24 h.
Cell viability assay
Cell viability was determined by the Vi-Cell (Beckman Coulter,
CA) cell counter that performs an automated trypan blue
exclusion assay.
Nuclear morphology study for apoptosis
Cell suspensions were cytospun onto clean fat-free glass slides
using a cytocentrifuge. Centrifuged samples were fixed for 10 min
in 4% paraformaldehyde and stained in 10 mg/ml PI for 30 min
at 4uC.
DNA electrophoresis
Cells (2610
6) were resuspended in 1.5 ml of lysis buffer [10 mM
Tris (pH 7.5), 10 mM EDTA (pH 8.0), 10 mM NaCl and 0.5%
SDS] into which proteinase K (200 mg/ml) was added. After
samples were incubated overnight at 48uC, 200 ml of ice cold 5 M
NaCl was added and the supernatant containing fragmented DNA
was collected after centrifugation. The DNA was then precipitated
overnight at 220uC in 50% isopropanol and RNase A-treated for
1 h at 37uC. A loading buffer containing 100 mM EDTA, 0.5%
SDS, 40% sucrose, and 0.05% bromophenol blue was added at
1:5 (v/v). Separation was achieved in 2% agarose gels in Tris-
Acetic acid/EDTA buffer (containing 0.5 mg/ml ethidium bro-
mide) using 50 mA for 1.5 h.
Pulsed-field gel electrophoresis (PFGE)
Cells (2610
6) were suspended in 50 ml of PBS containing 1%
low melting temperature agarose. The cell suspension was
poured into a template (562610 mm), plugged, and cooled on
ice. The hardened agarose gel blocks were incubated with
250 ml of a mixture of proteinase K (1 mg/ml), N-lauroyl
sarcosin sodium (1% w/v), and 0.5 M EDTA (pH 9.2) at 50uC
for 48 h. After incubation, half the volume of the digested
agarose gel block was loaded into a sample well of a 1% (w/v)
agarose gel (Sigma type II, 150615064.4 mm) in 0.56 TBE
buffer (89 mM Tris-boric acid, 2 mM EDTA, pH 8.0). PFGE
was carried out in 0.56TBE maintained at 14uC by circulating
cool water for 16 h (constant, 6 V; switch times are initial 60 sec
and final 90 sec), using the CHEF Mapper XA System from
Bio-Rad. DNA in the gel was stained with ethidium bromide
and detected with LAS-3000Plus (Fuji Photo Film Company,
Kanagawa, Japan).
Western blot analysis
Cells (2610
6) were washed twice with ice-cold PBS,
resuspended in 200 ml ice-cold solubilizing buffer [300 mM
NaCl, 50 mM Tris-Cl (pH 7.6), 0.5% TritonX-100, protease-
inhibitor cocktail] and incubated at 4uC for 30 min. The lysates
were centrifuged at 14,000 rpm for 20 min at 4uC. Protein
concentrations of cell lysates were determined with Bradford
protein assay reagent (Bio-Rad) and 40 mgo fp r o t e i n sw e r e
loaded onto 7.5–15% SDS/PAGE. The gels were transferred to
nitrocellulose membrane (Amersham Pharmacia Biotech, Pis-
cataway, NJ) and reacted with each antibody. Immunostaining
with antibodies was performed using the Super Signal West Pico
enhanced chemiluminescence substrate and detected with
LAS-3000PLUS.
Quantification of DNA hypoploidy and cell cycle phase
analysis by flow cytometry
Ice-cold 95% ethanol with 0.5% Tween-20 was added to cell
suspensions to a final concentration of 70% ethanol. Fixed cells
were pelleted and washed with PBS containing 1% bovine serum
albumin (BSA). Cells were resuspended in 1 ml PBS containing 11
Kunitz U/ml RNase, incubated at 4uC for 30 min, washed once
with BSA-PBS and resuspended in PI solution (50 mg/ml). After
the cells had been incubated at 4uC for 30 min in the dark and
washed with PBS, DNA content was measured using an Epics XL
(Beckman Coulter, FL), and the data were analyzed using the
Multicycle software which allowed a simultaneous estimation of
cell cycle parameters and apoptosis.
Immunofluorescence staining, confocal microscopy and
quantification
Cell suspensions were cytospun onto clean fat-free glass slides
using a cytocentrifuge. Cells were incubated with an LC3 primary
antibody for 1 h at 37uC, washed 3 times for 5 min each with
PBS, incubated with a FITC-conjugated secondary antibody for
1 h at room temperature and counterstained with DRAQ5
TM.
Fluorescence images were observed and analyzed using a Zeiss
LSM 510 laser-scanning confocal microscope (Go ˝ettingen,
Germany). To quantify those cells that showed a punctuate
pattern, at least 300 cells from each experiment were counted by
an observer who was blinded with regard to the experimental
group.
Transmission electron microscopy
Twenty four h after treatment, cells were harvested, pelleted
and fixed in 2.5% glutaraldehyde in phosphate buffer. After being
rinsed with phosphate buffer, the samples were postfixed in 1%
osmium tetroxide for 1 h, rinsed with water, dehydrated in a
graded series of ethanol followed by propylene oxide and kept
overnight in Epon812. The samples were embedded in Epon812
and cured in an oven at 60uC. Ultrathin sections were obtained
with a Reichert Ultracut E microtome. The sections were stained
with uranyl acetate and lead citrate and observed using a
transmission electron microscope (Hitachi). For each treatment
or control group, at least 200 cells from randomly chosen
transmission electron microscopy fields were observed.
TUNEL staining of cell suspensions
Cell suspensions were cytospun onto clean fat-free glass slides in
a cytocentrifuge. After being fixed with 4% paraformaldehyde, the
cells were incubated with terminal deoxynucleotidyl transferase
(TdT) enzyme for 1 h at 37uC, and antidigoxigenin-rhodamine
was applied for 30 min at room temperature. Afterward the cells
were incubated with an LC3 primary antibody for 1 h at 37uC.
Nuclei were counterstained with DRAQ5
TM. Fluorescent images
were observed and analyzed using a Zeiss LSM 510 laser-scanning
confocal microscope.
Autophagy flux assay
To analyze the flux of autophagy induced by cotreatment with
TNF-a and DRB cells were pretreated with bafilomycin for 24 h
and were further exposed to TNF-a in the presence or absence of
the CK2 inhibitor DRB for 24 h. Densitometric analysis of
endogenous LC3-I and -II detected by Western blot assay was
performed using Multi Gauge V2.1 (Fuji Photo Film Company,
Kanagawa, Japan). Quantification of cells showing a punctuate
pattern was performed described as above. Suppression by
bafilomycin A1 of the development of acidic vesicular organelles
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with 0.75 mM LysoTracker in the culture medium at 37uC for
30 min. After incubation, they were washed with PBS and
immediately analyzed by flow cytometry [excitation: 488 nm
(argon laser), emission filter: 620 nm] using an Epics XL.
Transfection of ATG5 and ATG7 small interfering RNA
The inhibition of autophagy was also carried out by knock-
down of ATG-5 or ATG-7 genes. Using BLOCK-iT
TM
Fluorescent Oligo for electroporation (Invitrogen), we first
optimized the conditions rat articular cartilage chondrocytes
transfection and achieved .90% transfection efficiency using an
electroporator (Neon
TM transfection system, Invitrogen). ATG5
and ATG7 stealth siRNAs were designed based on the rat ATG-5
(NM_001014250.1) and ATG-7 (NM_001012097.1) cDNA refer-
ence sequences using the BLOCK-iT
TM RNAi Designer (Invitro-
gen). ATG5 stealth siRNA were as follow: sense, 59-AUC UCA
UCC UGA UAG AGA GUA AAG C-39; antisense, 59-AAU
AGU AUG GCU CUG CUU CUC GUU C-39. ATG7 stealth
siRNA were as follow: sense, 59-AGA AGU AGC AGC CAA
GCU UGU AUC C-39; antisense, 59-GGA UAC AAG CUU
GGC UGC UAC UUC U-39. As a negative control, stealth RNAi
negative control (Invitrogen) was used. Chondrocytes were washed
in PBS and resuspended in resuspension buffer R included with
Neon
TM kit (Invitrogen). ATG5 or ATG7 stealth siRNA and
stealth RNAi negative control (each 200 nM) were electroporated
twice into chondrocytes with pulse voltage of 1300V and pulse
width of 20 ms using Neon
TM transfection system. Eletroporated
cells were resuspended in culture medium containing serum and
Figure 1. Decrease in CK2 activity in articular chondrocytes of
aged rats. Lysates from articular chondrocytes of 6-, 21- and 30-
month-old rats were used in kinase assays and quantified radioactivity
determined using a b-counter. CK2 activity in the articular chondrocytes
of 21- and 30-month-old rats was significantly decreased by 30% and
40%, respectively, compared to their 6-month-old counterparts
(** P,0.01). Values are expressed as mean 6 S.D.
doi:10.1371/journal.pone.0019163.g001
Figure 2. Facilitation of TNF-a-mediated chondrocyte death by CK2 inhibitors via apoptosis. To examine whether the inhibition of CK2
activity modulates the extent of TNF-a-mediated chondrocyte death, cells were co-treated with one of three CK2 inhibitors and TNF-a (50 ng/ml) for
24 h. Ctrl, control; A, apigenin; D, DRB; T, TBB; TNF, TNF-a. (A) Cells were harvested 24 h after treatment, and viability was determined using a cell
counter performing an automated trypan blue exclusion assay. CK2 inhibitors significantly facilitated TNF-a-mediated chondrocyte death compared
to TNF-a treatment alone (** P,0.01). Values are expressed as mean 6 S.D. (B) Representative histograms showing the percentage of subdiploid
apoptotic cells. DRB facilitated the TNF-a-induced accumulation of subdiploid apoptotic cells (arrows). (C) PI staining showed that DRB facilitated
TNF-a-induced nuclear condensation. (D) DNA electrophoresis and PFGE. hough conventional DNA electrophoresis did not reveal a DNA ladder (left
panel), PFGE revealed the disintegration of nuclear DNA into giant fragments of 1-2 Mbp and high molecular-weight fragments of 100-1000 Kbp in
cells co-treated with DRB and TNF-a. (E) A western blot assay showed that DRB facilitated the TNF-a-induced degradation of caspase-2L, -8, and -3
subtypes and the production of caspase-2L, -8 and -3 cleaved products. For this assay, cells were harvested 24, 48 and 72 h after treatment. b-actin, a
loading control.
doi:10.1371/journal.pone.0019163.g002
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a humidified 5% CO2 incubator. Cells were further exposed to
TNF-a in the presence of DRB for 24 h.
Rat OA model and human OA samples
Animals. Sprague-Dawley rats weighing 175–200 g were
used obtained from Samtako (Osan, Korea). A total of nine rats
were included in this group. The anterior cruciate ligament was
transected using a cutting hook. Animals were maintained in their
cages, where they moved freely without post-operative casts. After
three days, they were trained in a treadmill exercise box for the
next four weeks. Animals were then sacrificed. Both knee joints of
each animal were dissected, and the femoral condyles were fixed in
PBS (pH 7.4) containing 4% paraformaldehyde, decalcified in
12.5% EDTA, dehydrated and embedded in paraffin blocks. Non-
operated rats were used as a control.
Human OA samples. Human articular cartilage samples
were obtained from the knee joints of 25 patients (ages: 43–82
years; mean age: 68.4 years) during total knee replacement surgery
due to OA. All patients attended the Rheumatology Clinic at
Dong-A University Hospital (Busan, Korea). Full-thickness
cartilage slices were taken from the medial femoral condyles
above the subchondral bone. All patients were classified as
radiographically grade IV OA based on the Kellgren/Lawrence
(K/L) classification. In addition, healthy cartilage samples were
obtained from the autopsies of two accident victims (ages 22 and
24 years old). Cartilage samples were fixed in PBS (pH 7.4)
containing 4% paraformaldehyde, dehydrated and embedded in
paraffin blocks. This study was reviewed and approved by the
Dong-A University Hospital Institutional Review Board
(DUHIRB-10-10-23). Written informed consent was obtained
from all participants.
Tissue preparation and LC3 immunostaining
Five-micrometer microsections were prepared. The sections
were incubated with TdT enzyme for 1 h at 37uC, and
antidigoxigenin-rhodamine was applied for 30 min at room
temperature. Afterward the cells were incubated with an LC3
Figure 3. Autophagy is involved in the facilitation of TNF-a-mediated chondrocyte death by a CK2 inhibitor. For following assays, cells
were harvested 24 h after treatment. (A) A western blot assay showed an increase of LC3-II levels in cells co-treated with DRB and TNF-a. b-actin, a
loading control. (B) Immunofluorescence microscopy showed the appearance of a punctuate LC3 pattern in cells co-treated with DRB and TNF-a. (C)
Tranmission electron microscopy. Representative data are shown. Upper left panel: untreated control. This control cell showed a normal distribution
of organelles. Upper middle panel: the presence of phagopores (arrows) in cells co-treated with DRB and TNF-a. Upper right panel; early autophagic
cell with a nucleus and microvilli that appeared normal. This cell had numerous autophagic vacuoles in the cytoplasm, large vacuoles approaching
mitochondria (arrow) and membrane whorls. Lower panel: several cells with features of late-stage cell death. Cells were round and had no microvilli.
Vacuoles contained phagocytosed cell fragments and myelin figures (cell a). Most cells with features of this late autophagic cell death showed
peripheral chromatin condensation in their nuclei, a hallmark of apoptosis (cells a and b). In a highly vacuolated cell with features of very late cell
death, all cell organelles had disappeared (cell c). Another cell showed features of very late cell death (cell d); its nucleus was highly condensed, and
no cytoplasmic components, including vacuoles, were observable. See Figure 2 for other definitions.
doi:10.1371/journal.pone.0019163.g003
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observed and photographed using a Zeiss LSM 510 laser-scanning
confocal microscope under DIC optics without counterstaing.
Statistical analysis
Four independent experiments were carried out in vitro. The
results are expressed as means 6 S.D. from four experiments, each
performed in triplicate.
Results
Decrease in CK2 activity in chondrocytes of rat articular
cartilage
CK2 activity was significantly decreased in rat articular
cartilage chondrocytes with advancing age. CK2 activity in the
articular chondrocytes of 21- and 30-month-old rats was decreased
by 30% and 40%, respectively, compared to their 6-month-old
counterparts (Fig. 1).
CK2 inhibitors facilitate TNF-a-mediated chondrocyte
death via apoptosis
To build an in vitro experimental system for simulating TNF-
a-induced cell death in aged chondrocytes with decreased CK2
activity, we used CK2 inhibitors. To examine whether the
inhibition of CK2 activity modulates the extent of TNF-a-
mediated chondrocyte death, cells were co-treated with one of
three CK2 inhibitors (apigenin, DRB or TBB) and TNF-a.T h e
viability assay showed that treatment with CK2 inhibitors alone
at concentrations of 75 and 100 mMl e dt oas l i g h td e c r e a s ei n
chondrocyte viability (Figure S1). Importantly, downregulation
of CK2 activity by these inhibitors facilitated TNF-a-mediated
chondrocyte death (Fig. 2A). Because the CK2 inhibitors
significantly facilitated TNF-a-mediated chondrocyte death at
100 mM, this single concentration was used to further explore
the mechanism underlying this process. At this dose, CK2
inhibitors decreased CK2 activity in chondrocytes to approx-
i m a t e l yh a l fi nc o m p a r i s o nw i t ht h ec o n t r o lc e l l s .W ef i r s t
undertook various assays to test whether this cell death
induction is mediated via apoptosis. Flow cytometry demon-
strated the accumulation of subdiploid cells (Fig. 2B), and the
nuclear morphology assay showed nuclear condensation
(Fig. 2C). Although cells that were co-treated with DRB and
TNF-a failed to show ladder-like DNA fragments from their
genomic DNA on a standard agarose gel, PFGE revealed the
disintegration of nuclear DNA into giant fragments of 1-2 Mbp
and high molecular-weight fragments of 100–1000 Kbp
( F i g .2 D ) .C o n s i d e r i n gt h a tc a s p a s e sw e r ek n o w nt op l a y
essential roles in most types of apoptosis, we examined whether
caspase subtypes were activated after co-treatment of DRB and
TNF-a. A western blot assay showed that caspase-2L, -8, and -3
were activated in cells co-treated with DRB and TNF-a
(Fig. 2E). These data support the idea that inhibition of CK2
activity facilitates TNF-a-mediated chondrocyte death via
apoptosis. Another CK2 inhibitor, apigenin, showed similar
Figure 4. Prevention of lysosomal degradation by bafilomycin
A1 enhanced the amount of LC3-II and the appearance of a
punctuate LC3 pattern in chondrocytes co-treated with TNF-a
and DRB. Cells were pretreated with bafilomycin A1 for 24 h and were
further exposed to TNF-a in the presence or absence of the CK2
inhibitor DRB for 24 h. Baf, bafilomycin A1. (A) A western blot assay
showed that an increase in LC3-II levels in cells co-treated with DRB and
TNF-a was enhanced by bafilomycin A1 treatment. b-actin, a loading
control. (B) Confocal microscopy and quantification assay demonstrated
that the appearance of a punctuate LC3 pattern in chondrocytes co-
treated with DRB and TNF-a was enhanced by bafilomycin A1 treatment
(* P,0.05). (C) Flow cytometry demonstrated that bafilomycin A1
suppressed the development of acidic vesicular organelles. Bafilomycin
A1 significantly decreased the cells having LysoTracker-positive
vacuoles (** P,0.01). See Figure 2 for other definitions.
doi:10.1371/journal.pone.0019163.g004
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(Figure S2). Silencing of CK2a by siRNA also facilitated
TNF-a-mediated chondrocyte death (Figure S3A). Overexpres-
sion of CK2a reduced TNF-a-mediated chondrocyte death
(Figure S3B).
Autophagy is involved in facilitating the TNF-a-mediated
chondrocyte death induced by CK2 inhibitors
We next tested whether another cell death mode, autophagy,
was involved in this cell death induction. We first examined the
conversion of LC3 from an 18-kDa form (LC3-I) to a faster-
migrating 16-kDa form (LC3-II). A western blot assay
demonstrated an increase in LC3-II levels in cells co-treated
with DRB and TNF-a but not in cells treated with DRB or
TNF-a alone (Fig. 3A). Fluorescence microscopy demonstrated
that the number of cells showing a punctuate LC3 pattern,
indicating LC3 aggregation, increased with co-treatment of
DRB and TNF-a (Fig. 3B). We next used transmission electron
microcopy to confirm the presence of autophagic vacuoles in
cells co-treated with DRB and TNF-a (Fig. 3C). We observed
t h ep r e s e n c eo fp h a g o p h o r e si nc e l l sc o - t r e a t e dw i t hD R Ba n d
TNF-a (Fig. 3C, phagophores). Early autophagic cells which
had nuclei and microvilli with normal appearances had
autophagic vacuoles (Fig. 3C, e a r l y ) .I nt h e s ec e l l s ,s o m e
vacuoles were approaching mitochondria and contained
membrane whorls. We also observed cells with features of
late-stage cell death (Fig. 3C, late): those cells were round and
had no microvilli, and their vacuoles contained phagocytosed
cell fragments and myelin figures. Importantly, most cells
showing features of this late autophagic cell death showed
peripheral chromatin condensation in their nuclei, a hallmark
of apoptosis. We also observed cells with features of later-stage
cell death. In those highly vacuolated cells, all cell organelles
had disappeared. We also observed cells with features of very
late-stage cell death, in which all cytoplasmic components,
including vacuoles, were degrade d ,a n dt h en u c l e iw e r eh i g h l y
condensed.
Prevention of lysosomal degradation by bafilomycin A1
enhanced the amount of LC3-II and the appearance of a
punctuate LC3 pattern in chondrocytes co-treated with
TNF-a and DRB
We further analyzed autophagy flux based on turnover of LC3-
II by western blot in the presence and absence lysosomal
degradation. To prevent lysosomal degradation, bafilomycin A1
was used [27,28]. Considering that bafilomycin A1 is toxic to cells
Figure 5. LC3 puncta were detected in TUNEL positive apoptotic cells. In a group co-treated with DRB and TNF-a for 24 h, a cell showing a
punctuate LC3 pattern is TUNEL positive (arrow). See Figure 2 for other definitions.
doi:10.1371/journal.pone.0019163.g005
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dose at which bafilomycin A1 did not yield any significant cellular
damage after three days in culture. A western blot assay showed
that an increase in LC3-II levels in cells co-treated with DRB and
TNF-a was markedly enhanced by bafilomycin A1 treatment
(Fig. 4A). Confocal microscopic observation and quantification
assay revealed that the appearance of a punctuate LC3 pattern in
chondrocytes co-treated with DRB and TNF-a was enhanced by
bafilomycin A1 treatment (Fig. 4B). The observation and
quantification of cells with LysoTracker-labeled organelles and
flow cytometry analysis demonstrated that bafilomycin A1
suppressed the development of acidic vesicular organelles in co-
treated cells (Fig. 4C).
LC3 punta were detected in TUNEL positive cells
We further examined whether that a punctuate LC3 pattern
was observed in cells undergoing apoptosis. Noticeably, we
observed a punctuate LC3 pattern in TUNEL positive cells
(Fig. 5). Approximately 30% of cells showing LC3 punta were
TUNEL positive.
Inhibition of autophagy by 3MA or siRNA against
autophagy-related genes protects chondrocytes against
apoptosis as well as autophagy
We next tested whether pharmacological inhibition of autoph-
agy by 3MA has impacts on the autophagic events of chondrocytes
co-treated with DRB and TNF-a. Considering that 3MA is toxic
to cells to some extent, we treated cells with 1 mM 3MA, the dose
at which 3 MA did not yield any significant cellular damage after
three days in culture. A western blot assay showed that 3MA
suppressed the conversion of LC3 from LC3-I to LC3-II. Confocal
microscopic observation and quantification assay revealed that
3MA suppressed the appearance of a punctuate LC3 pattern in
chondrocytes co-treated with DRB and TNF-a (Fig. 6A). These
data indicate 3MA efficiently protected chondrocyte against
autophagy. We next investigated whether inhibition of autophagy
by 3MA affects the induction of apoptosis in chondrocytes co-
treated with DRB and TNF-a. Our viability assay showed that
3MA protected chondrocytes against cell death (Fig. 6B). Flow
cytometry demonstrated that 3MA prevented the accumulation of
subdiploid cells (Fig. 6C). Moreover 3MA protected chondrocytes
Figure 6. Inhibition of autophagy by 3MA protects chondrocytes against apoptosis as well as autophagy. Cells were pretreated with
3MA for 24 h, and were further exposed to TNF-a in the presence of the CK2 inhibitor DRB for 24 h. 3MA, 3-methyladenine. (A) A western blot assay
showed that 3MA suppressed the conversion of LC3 from LC-3I to LC-3II. Confocal microscopy also demonstrated that 3MA suppressed the
appearance of a punctuate LC3 pattern. The graph showing the quantification data of the fraction of cells with puncta supported that 3MA
significantly suppressed puncta formation (** P,0.01). b-actin, a loading control. (B) A viability assay showed that 3MA significantly protected
chondrocytes against cell death (** P,0.01). (C) Flow cytometry demonstrated that 3MA prevented the accumulation of subdiploid cells. (D) A
western blot assay showed that 3MA protected chondrocytes against the activation of caspase-2L, -8, and -3. See Figure 2 for other definitions.
doi:10.1371/journal.pone.0019163.g006
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with DRB and TNF-a (Fig. 6D). These findings suggest that the
inhibition of autophagy by 3 MA prevents the activation of caspase
subtypes and results in the protection of cells against apoptosis.
The inhibition of autophagy was also carried out by knock-down
of ATG-5 and ATG-7 genes. A western blot assay showed that
siRNA against ATG-5 efficiently reduced the expression level of
ATG-5 protein and that siRNA against ATG-5 efficiently
suppressed the conversion of LC3 from LC3-I to LC3-II. Confocal
microscopic observation revealed that siRNA against ATG-5
suppressed the appearance of a punctuate LC3 pattern in
chondrocytes co-treated with DRB and TNF-a (Fig. 7A). Viability
assay showed that siRNA against ATG-5 protected chondrocytes
against cell death (Fig. 7B). Flow cytometry demonstrated that
siRNA against ATG-5 prevented the accumulation of subdiploid
cells (Fig. 7C). Furthermore, siRNA against ATG-5 protected
chondrocytes against the activation of caspase-2L, -8, and -3 by
the co-treament with DRB and TNF-a (Fig. 7D). siRNA against
ATG-7 also efficiently reduced the expression level of ATG-7
protein (Fig. 7E) and protected chondrocytes against apoptosis as
Figure 7. siRNA against ATG-5 protects chondrocytes against apoptosis as well as autophagy. For following assays, cells were harvested
24 h after treatment. NC siRNA, RNAi negative control; b-actin, a loading control. (A) A western blot assay showed that siRNA against ATG-5 efficiently
reduced the expression level of ATG-5 protein and suppressed the conversion of LC3 from LC3-I to LC3-II. Confocal microscopy indicated that siRNA
against ATG-5 suppressed the appearance of a punctuate LC3 pattern in chondrocytes co-treated with DRB and TNF-a. (B) A viability assay showed
that siRNA against ATG-5 significantly protected chondrocytes against cell death (** P,0.01). (C) Flow cytometry demonstrated that siRNA against
ATG-5 prevented the accumulation of subdiploid cells. (D) A western blot assay showed that siRNA against ATG-5 protected chondrocytes against the
activation of caspase-2L, -8 and -3. (E) A western blot assay showing that siRNA against ATG-7 efficiently reduced the expression level of ATG-7
protein. See Figure 2 for other definitions.
doi:10.1371/journal.pone.0019163.g007
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increased autophagosome formation is required for the induction
of apoptosis in articular chondrocytes.
LC3-II-positive autophagic cells were detected in
cartilage obtained from OA model rats and human OA
patients
Finally, we examined whether autophagy was involved in OA
pathogenesis. Compared to the control rats, the expression level of
LC3 was higher in chondrocytes of the cartilage obtained from
OA model rats (Fig. 8A). Noticeably, chondrocytes of OA model
rats showed a punctuate LC3 pattern. However, chondrocytes of
the cartilage obtained from control rats displayed diffuse LC3
staining. Among 9 animals tested, 7 showed LC3-II-positive cells.
We observed a punctuate LC3 pattern in TUNEL positive cells
(Fig. 8A). Chondrocytes of the cartilage obtained from human OA
patients also showed a punctuate LC3 pattern (Fig. 8B). Among 20
samples tested, 12 showed LC3-II-positive cells. The expression
level of LC3 in chondrocytes of the cartilage obtained from control
human was so low that not even diffuse LC3 staining was
observable. We observed a punctuate LC3 pattern in TUNEL
positive cells (Fig. 8B). Approximately 30% of cells showing LC3
punta were TUNEL positive in both experimental groups. To this
end, we examined whether autophagic and apoptotic events
increase in rat articular cartilage chondrocytes with advancing age.
Expression levels of LC3-II and caspase-3 cleavage product in the
articular chondrocytes of 21- and 30-month-old rats were
increased compared to their 6-month-old counterparts (Figure S4).
Discussion
The present study elucidated that CK2 activity in articular
chondrocytes is decreased in aged rats compared to young controls
and that downregulation of CK2 activity facilitates TNF-a-
mediated chondrocyte death. Although several previous reports
showed that CK2 modulates TNF-a mediated cell death [29-31],
the modulation of TNF-a-mediated chondrocyte death by CK2
has not been well studied. Because TNF-a is a major factor
inducing chondrocyte death, we hypothesized that the downreg-
ulation of CK2 activity in aged articular chondrocytes is involved
in OA pathogenesis.
Despite the large number of studies in this field, controversies
regarding the definition of cell death and the classification of cell
death types have not yet been resolved. Cell death can be classified
according to morphological appearance, enzymological criteria,
functional aspects or immunological characteristics. Based on
morphological criteria, three types of cell death can be defined:
apoptosis, autophagy and necrosis. However, several critiques
have been raised against the clear-cut distinctions of these three
types of cell death. To date, a clear equivalence between
ultrastructural alterations and biochemical cell death characteris-
tics has not been established [32,33].
Autophagy has been used to describe the catabolic pathways of
the degradation of intracellular macromolecules. Autophagy starts
with the sequestration of cytoplasmic organelles in a membrane
vacuole called an autophagosome. Next, autophagosomes fuse
with lysosomes, in which cellular materials are degraded and
recycled. Because numerous recent studies have shown that
increased autophagic activity is associated with cell death [34-36],
autophagy is now considered to be a type of cell death. Autophagic
cell death is accompanied by massive autophagic vacuolation.
Autophagic cell death involves the caspase-dependent mechanism
in some contexts but not in others [37,38]. Although the
involvement of autophagy in cell death has been elucidated in
multiple experimental and physiological settings, the role of
autophagy in dying cells remains a subject of debate [39,40].
Autophagy can exert both cytoprotective and cell death functions,
depending on the specific cellular conditions. On one hand,
autophagy can promote the survival of dying cells in the absence of
apoptosis [41], and the inhibition of autophagy triggers apoptotic
cell death [42,43]. On the other hand, in certain settings, the
inhibition of autophagy at an early stage can prevent the induction
of apoptosis [44].
Arguably, the most intriguing finding of our study is the
participation of autophagy in chondrocyte death. To date, little
progress has been made in understanding the participation of
autophagy in the regulation of chondrocyte death. Most previous
studies of chondrocyte autophagy had examined the fate of growth
plate chondrocytes [45–48]. These studies demonstrated that
autophagy plays a cyto-protective role in chondrocytes and that
the suppression of autophagy leads to elevated cell death [46,47].
However, in other settings, 3MA-treated chondrocytes became
refractory to cell death stimuli, suggesting that sustained
autophagy promotes cell death [45]. Uncoupling protein 3,
PIM-2 (proviral integration of Moloney virus) and hypoxia-
inducible factor 1 and 2 are known to regulate chondrocyte
autophagy [45–47,49,50]. In addition, those studies showed that
autophagy undergoes cross-talk with apoptosis via classical
apoptotic mediators such as BID and Bad [46,47]. Aside from
these studies, little information exists concerning the molecular
mechanisms underlying the regulation of chondrocyte apoptosis by
autophagy.
In the present study, we revealed the findings supporting the
induction of autophagy, as well as apoptosis, in chondrocytes co-
treated with DRB and TNF-a. Importantly, the inhibition of
autophagy by 3MA or siRNA against ATG-5 and -7 prevented the
activation of caspase subtypes and protected chondrocytes against
apoptosis. Although our data do not exclude the possibility that
autophagy and apoptosis may contribute to cell death indepen-
dently, autophagy, at least in part, leads to the induction of
apoptosis in chondrocytes co-treated with DRB and TNF-a. The
presence of this cross-talk between apoptosis and autophagy is
additionally supported by EM data, which show numerous
vacuoles in cells with apoptotic nuclei. The appearance of a
punctuate LC3 pattern in apoptotic cells that show positive
TUNEL staining also supports the presence of this cross-talk. The
present study suggests that autophagy can participate in OA
pathogenesis. Since most previous efforts to understand the
detailed mechanism of chondrocyte death pertaining to OA
pathogenesis have been devoted to the study of apoptosis [3,9,22],
much less is known currently about the involvement of autophagy
in OA pathogenesis. A report demonstrated that, with aging and
the onset of osteoarthritis, the subsequent lowered expression of
HIF-2a causes an increase of chondrocyte autophagy and the
Figure 8. Demonstration of LC3-II positive punctuate autophagic cells in cartilage obtained from OA model rats and human OA
patients. Fluorescent images were observed and photographed using a laser-scanning confocal microscope under DIC optics without
counterstaing. (A) Chondrocytes in cartilage obtained from OA model rats display a punctuate LC3 pattern. Several cells showing autophagic LC3
puncta are TUNEL positive. (B) Chondrocytes from cartilage obtained from human OA patients display a punctuate LC3 pattern. Several cells showing
autophagic LC3 puncta are TUNEL positive. Representative data are shown.
doi:10.1371/journal.pone.0019163.g008
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apoptogen challenges [45]. Another report elucidated that high
incidence of active caspase 3 as well as LC3-II expression are
observed in the same cell of the superficial and middle zones of
articular cartilage, indicating that the degenerations of cartiage
results from a combination of apoptosis and autophagy [51]. In
the present study, we observed that downregulation of CK2
activity facilitated TNF-a-mediated chondrocyte death through
autophagy in vitro. Furthermore, we observed autophagic cells in
cartilage obtained from OA model rats and human OA patients.
The present study with the two previous reports [45,51] suggests
that autophagy participates in OA pathogenesis although it
should be clarified in the future if autophagy observed is a
consequence versus a cause of the degeneration in vivo
Conversely, a previous study reported that autophagy is a
protective mechanism in normal cartilage, and its aging-related
loss is linked with cell death and osteoarthritis [52]. These
opposing findings suggest that functional relationship between
apoptosis and autophagy during OA pathogenesis appears to be
complex. While autophagy probably could be activated as an
adaptive response to avoid cell death, this process also appears to
be conjunctly activated with apoptosis. Although these reports
mutually contradictory, they suggest the possibility that compro-
mised autophagy may contribute to the development of OA.
Thus, the potential role of autophagy in the development of
osteoarthritis should be further examined in the future.
Another interesting finding in the present study is the
involvement of CK2 in chondrocyte autophagy. CK2 is well
known as a major kinase participant in apoptosis regulation. The
regulation of apoptosis by CK2 has been studied extensively.
However, understanding the regulation of autophagy by CK2 is
fragmentary. Although we speculate that downregulation of CK2
activity modulates the molecules involved in the autophagy
pathway, the signaling pathway by which CK2 regulates
autophagy remains to be determined.
Because cell death mechanisms play a role in OA pathogenesis,
modulation of these mechanisms may have substantial therapeutic
potential. The data presented here underline the importance of the
treatment approaches of targeting apoptosis and autophagy for
OA. Considering that these approaches should target both
apoptotic and autophagic pathways, deciphering the detailed
molecular mechanism by which CK2 modulates chondrocyte
death via multiple pathways is an important and challenging task.
Taken together, we conclude that downregulation of CK2
activity facilitates TNF-a-mediated chondrocyte death through
apoptosis and autophagy.
Supporting Information
Figure S1 Slight reduction in chondrocyte viability by
CK2 inhibitors. Cells were treated with one of three CK2
inhibitors (apigenin, DRB or TBB) for 24 h. Viability was
determined by a cell counter performing an automated trypan
blue exclusion assay. Treatment with two CK2 inhibitors
(apigenin and DRB) at a concentration of 75 and 100 mM led to
a slight reduction in chondrocyte viability.
(TIF)
Figure S2 Facilitation of TNF-a-mediated chondrocyte
death by apigenin via apoptosis. In addition to DRB,
apigenin (100 mM) facilitated TNF-a-mediated chondrocyte death
via apoptosis. The facilitation of the activation of caspase subtypes
by apigenin is presented.
(TIF)
Figure S3 Effects of CK2a knockdown and overexpres-
sion on TNF-a-mediated chondrocyte death. (A) TNF-a-
mediated chondrocyte death was significantly facilitated by
silencing of CK2a by siRNA (** P,0.01). CK2 stealth siRNA
were as follow: sense, 59-CAA ACU AUA AUC GUA CAU C-39;
antisense, 59-GAU GUA CGA UUA UAG UUU G -39.A sa
negative control, stealth RNAi negative control (Invitrogen) was
used. Transfection procedure is described in Materials and
Methods. Cells were further exposed to 50 ng/ml TNF-a for 24
h. NC siRNA, RNAi negative control. (B) TNF-a-mediated
chondrocyte death was significantly reduced by overexpression of
CK2a (** P,0.01). Full-length CK2a was cloned by amplifying
the rat cDNA with primers 59-ATAGAATTCATGTCGG-
GACCCGTGCCAAGCAG-39 (EcoRI site underlined) and 5-
GCATCTAGATTACTGCTGAGCGCCAGCGG-39 (XabI site
underlined). The PCR product was subcloned into the mamma-
lian expression vector pcDNA3. Transfection procedure is
described in Materials and Methods. Cells were further exposed
with 50 ng/ml TNF-a in parallel with 100 mM DRB for 24 h. Ctrl,
untransfected control cells. Vec, cells tranfected with pcDNA3
vector.
(TIF)
Figure S4 Autophagic and apoptotic events increase in
rat articular cartilage chondrocytes with advancing age.
Articular chondroctyes obtained from 6-, 21- and 30-month-old
rats were used for western blot assay. (A) A western blot showing
that expression levels of LC3-II of 21- and 30-month-old rats
were increased compared to their 6-month-old counterpart. (B)
A western blot showing that expression levels of caspase-3
cleavage product in the articular chondrocytes of 21- and 30-
month-old rats was increased compared to their 6-month-old
counterpart.
(TIF)
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